Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Cancer Res. 2009 Jan 1;69(1):37–44. doi: 10.1158/0008-5472.CAN-08-1648

Figure 5. Aberrant activation of CREB in TGFBI−/− MEFs.

Figure 5

(A) mRNA level of cyclin D1 in TGFBI−/− and wild type MEFs determined by real time RT-PCR. (B) Levels of p-CREB and cyclin D1 in serum-stimulated wild type and TGFBI−/− MEFs examined by Western blots. (C) Relative pCRE-luc activity in wild type and TGFBI−/− MEFs. (D) Relative pCRE-luc activity in wild type and TGFBI−/− MEFs after co-transfection of pCRE-luc with WT-CREB or DN-CREB vectors.